Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
Male Breast Cancer
ClinicalTrials.gov recordTREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
The approach to the treatment of men with breast cancer is similar to that for women. Because male breast cancer is rare, there is a lack of randomized data to support specific treatment modalities. Treatment options for men with breast cancer are described in Table 1.
Sources: Table 1
| Stage (TNM Definitions) | Treatment Options |
|---|---|
| T = primary tumor; N = regional lymph node; M = distant metastasis; GnRH = gonadotropin-releasing hormone. | |
| Early/localized/operable male breast cancer | Surgery with or without radiation therapy |
| Adjuvant therapy | |
| Locally advanced male breast cancer | Neoadjuvant chemotherapy |
| Surgical excision | |
| Radiation therapy and endocrine therapy | |
| Metastatic male breast cancer | Aromatase inhibitor therapy in conjunction with a GnRH agonist |
Sources: TNM Definitions · Surgery with or without radiation therapy · Adjuvant therapy · Neoadjuvant chemotherapy · Surgical excision · Radiation therapy and endocrine therapy · Aromatase inhibitor therapy in conjunction with a GnRH agonist
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
As in women, treatment options for men with early-stage breast cancer include:
Surgery with or without radiation therapy (locoregional therapy).
Adjuvant therapy (systemic therapy).
Sources: Adjuvant therapy
Adjuvant therapy (systemic therapy).
Chemotherapy.
Endocrine therapy.
Human epidermal growth factor receptor 2 (HER2)–directed therapy.
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
Primary treatment is a mastectomy with axillary lymph node dissection.[1-3] Responses in men are generally similar to those seen in women with breast cancer.[2] Breast conservation surgery with lumpectomy and radiation therapy has also been used and can be offered if standard criteria for breast conservation therapy are met. Results in men have been similar to those seen in women with breast cancer.[4]
For more information, see the Surgical Treatment for Breast Cancer section in Breast Cancer Treatment.
Sources: Surgical Treatment for Breast Cancer
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
The optimal systemic treatment in men with breast cancer has not been studied in randomized clinical trials. Adjuvant therapy should be administered according to the same criteria used for women. Adjuvant therapies used to treat early/localized/operable male breast cancer are outlined in Table 2. For more information, see the Systemic Therapy for Stages I, II, and III Breast Cancer section in Breast Cancer Treatment.
Sources: Table 2 · Systemic Therapy for Stages I, II, and III Breast Cancer
| Type of Adjuvant Therapy | Agents Used |
|---|---|
| HER2 = human epidermal growth factor receptor 2; LHRH = luteinizing hormone-releasing hormone. | |
| Chemotherapy | Docetaxel and cyclophosphamide |
| Doxorubicin plus cyclophosphamide with or without paclitaxel | |
| Endocrine therapy | Tamoxifen [5] |
| Aromatase inhibitors with LHRH agonist [5-9] | |
| HER2-directed therapy | Trastuzumab [1,5] |
| Pertuzumab | |
Tamoxifen
Evidence (tamoxifen):
A retrospective analysis of 257 men with stage I to stage III breast cancer included 50 men who were treated with an aromatase inhibitor (AI) and 207 men who were treated with tamoxifen.[10]
Sources: 10
A retrospective analysis of 257 men with stage I to stage III breast cancer included 50 men who were treated with an aromatase inhibitor (AI) and 207 men who were treated with tamoxifen.[10]
With a median follow-up of 42 months, treatment with an AI was associated with a higher risk of death compared with tamoxifen (32% with AI vs. 18% with tamoxifen; hazard ratio, 1.55; 95% confidence interval, 1.13–2.13).
In men with contraindications for tamoxifen, single-agent AI therapy is not recommended. AIs should be combined with gonadotropin-releasing hormone (GnRH) analogues.[6]
Sources: 6
In male breast cancer patients, tamoxifen use is associated with a high rate of treatment-limiting symptoms such as hot flashes and impotence.[11]
Sources: 11
The German Breast Group conducted a randomized phase II clinical trial (NCT01638247) of tamoxifen with or without a GnRH analogue versus AI plus a GnRH analogue in men with early-stage, hormone receptor–positive breast cancer. Results of this trial are pending.
Sources: NCT01638247
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
Treatment options for men with locally advanced breast cancer include:[1]
Sources: 1
Neoadjuvant chemotherapy.
Surgical excision.
Radiation therapy and endocrine therapy.
The decisions regarding the order and choice of treatments in men are guided by the same principles used for the treatment of breast cancer in women (in particular, evaluation of pathological response).[1,2]
For more information, see the Treatment of Locoregional Recurrent Breast Cancer section in Breast Cancer Treatment.
Source: Male Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 28, 2025. Captured 2026-09-09.
Treatment options for men with metastatic breast cancer include:
Aromatase inhibitor (AI) therapy in conjunction with a gonadotropin-releasing hormone (GnRH) agonist.
The management of metastatic hormone receptor–positive male breast cancer relies on the same treatment options used in women. However, data regarding the activity of AIs with GnRH agonists and fulvestrant in men are limited to case series.[1-4] The administration of an AI in conjunction with a GnRH agonist is recommended on the basis of the adjuvant data. There are no data comparing the activity of fulvestrant alone with fulvestrant in combination with a GnRH agonist.
Based on real world data and limited studies, it is reasonable to extrapolate the use of additional treatment options for men. These treatment options include cyclin-dependent kinase (CDK) 4/6 inhibitors, mammalian target of rapamycin (mTOR) inhibitors, and phosphatidylinositol-3 kinase (PI3K) inhibitors, used in combination with endocrine therapy.
The use of chemotherapy, human epidermal growth factor receptor 2 (HER2)-targeted therapy, immunotherapy, and poly (ADP-ribose) polymerase (PARP) inhibitors in men with metastatic breast cancer is guided by similar treatment principles as in women.[5,6]
For more information, see the Treatment of Metastatic Breast Cancer section in Breast Cancer Treatment.
Source: Male Breast Cancer, National Cancer Institute.
Source updated: December 2, 2025. Captured 2026-09-09.
How is male breast cancer treated?
Male breast cancer is usually treated in the same way as breast cancer in women. However, men are more likely than women to have a mastectomy (surgery to remove the whole breast) rather than a lumpectomy (breast-conserving surgery) to remove the cancer because they have less breast tissue. But some male breast cancers can be treated with a lumpectomy, depending on the size of the cancer, the amount of breast tissue the person has, and other factors.
Sources: mastectomy · lumpectomy
Learn more about breast cancer treatment at:
Ductal Carcinoma in Situ
Sources: Ductal Carcinoma in Situ
Breast Cancer Treatment by Stage
Sources: Breast Cancer Treatment by Stage
Metastatic Breast Cancer
Sources: Metastatic Breast Cancer
Male Breast Cancer
ClinicalTrials.gov recordTreatment of Early/Localized/Operable Male Breast Cancer
Treatment of Locally Advanced Male Breast Cancer
Male Breast Cancer
Treatment of Metastatic Male Breast Cancer